Literature DB >> 12453469

Regulation of growth-related genes by interleukin-6 in murine myeloma cells.

Serge Côté1, Carl Simard, Réal Lemieux.   

Abstract

Interleukin-6 (IL-6), a pleiotropic cytokine with effects on several hematopoietic and other normal cells, is also important for the growth and survival of tumor cells such as murine plasmacytomas and human myelomas. Exploiting the 11A3 hybridoma cell line for its IL-6 requirement to proliferate in vitro, we used subtractive suppression hybridization (SSH) to identify genes whose expression is stimulated and/or repressed in response to IL-6. Northern blot analysis of 100 arbitrarily picked subtracted cDNA clones revealed that expression of 11 mRNAs were IL-6-modulated. Among these, eight were genes known to encode a variety of proteins such as enzymes (PCK, MTDNI), structural proteins (Tropoelastin), transcriptional regulators (BRG1) and proteins involved in cell division control (Cyclin A, OAZi) or cell signaling (PIX, TOPK/PBK). The recently identified MAPKK-like protein kinase TOPK/PBK gene represents a likely candidate IL-6 target gene as suggested by its significant up-regulated expression in hybridoma cells induced to grow by a brief IL-6 pulse. The diversity of growth-related genes identified in this study further emphasizes the central role of IL-6 in the regulation of myeloma cell expansion in addition to its previously demonstrated role in the inhibition of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12453469     DOI: 10.1006/cyto.2002.1988

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  7 in total

1.  Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer.

Authors:  Christopher Johnson; Yuyan Han; Nathan Hughart; Jennifer McCarra; Gianfranco Alpini; Fanyin Meng
Journal:  Transl Gastrointest Cancer       Date:  2012-04-01

2.  T-LAK cell-originated protein kinase (TOPK) phosphorylation of Prx1 at Ser-32 prevents UVB-induced apoptosis in RPMI7951 melanoma cells through the regulation of Prx1 peroxidase activity.

Authors:  Tatyana A Zykova; Feng Zhu; Tatyana I Vakorina; Jishuai Zhang; Lee Ann Higgins; Darya V Urusova; Ann M Bode; Zigang Dong
Journal:  J Biol Chem       Date:  2010-07-20       Impact factor: 5.157

3.  Lymphokine-activated killer T-cell-originated protein kinase phosphorylation of histone H2AX prevents arsenite-induced apoptosis in RPMI7951 melanoma cells.

Authors:  Tatyana A Zykova; Feng Zhu; Chengrong Lu; LeeAnn Higgins; Yasuaki Tatsumi; Yasuhito Abe; Ann M Bode; Zigang Dong
Journal:  Clin Cancer Res       Date:  2006-12-01       Impact factor: 12.531

4.  In silico structural and functional analysis of the human TOPK protein by structure modeling and molecular dynamics studies.

Authors:  Palani Kirubakaran; Muthusamy Karthikeyan; Kh Dhanachandra Singh; Selvaraman Nagamani; Kumpati Premkumar
Journal:  J Mol Model       Date:  2012-09-01       Impact factor: 1.810

5.  Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells.

Authors:  M Amit-Vazina; S Shishodia; D Harris; Q Van; M Wang; D Weber; R Alexanian; M Talpaz; B B Aggarwal; Z Estrov
Journal:  Br J Cancer       Date:  2005-07-11       Impact factor: 7.640

6.  PBK/TOPK Inhibitor Suppresses the Progression of Prolactinomas.

Authors:  Kejing Zhu; Xueting Cheng; Shuman Wang; Hong Zhang; Yu Zhang; Xiong Wang; Yonggang Chen; Jinhu Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-21       Impact factor: 5.555

Review 7.  PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential.

Authors:  Hai Huang; Mee-Hyun Lee; Kangdong Liu; Zigang Dong; Zeayoung Ryoo; Myoung Ok Kim
Journal:  Cancers (Basel)       Date:  2021-05-06       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.